Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $38.6 million.

  • Cellebrite DI's Other Operating Expenses rose 1971.25% to $38.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.6 million, marking a year-over-year increase of 2015.04%. This contributed to the annual value of $132.2 million for FY2024, which is 1931.97% up from last year.
  • Per Cellebrite DI's latest filing, its Other Operating Expenses stood at $38.6 million for Q3 2025, which was up 1971.25% from $38.7 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Other Operating Expenses registered a high of $38.8 million during Q1 2025, and its lowest value of $16.5 million during Q1 2021.
  • Moreover, its 5-year median value for Other Operating Expenses was $27.1 million (2023), whereas its average is $27.9 million.
  • In the last 5 years, Cellebrite DI's Other Operating Expenses skyrocketed by 3440.49% in 2022 and then skyrocketed by 646.63% in 2023.
  • Quarter analysis of 5 years shows Cellebrite DI's Other Operating Expenses stood at $20.1 million in 2021, then increased by 17.32% to $23.5 million in 2022, then grew by 25.52% to $29.5 million in 2023, then increased by 20.25% to $35.5 million in 2024, then rose by 8.76% to $38.6 million in 2025.
  • Its Other Operating Expenses was $38.6 million in Q3 2025, compared to $38.7 million in Q2 2025 and $38.8 million in Q1 2025.